Natera Inc. (NASDAQ:NTRA) is a leading company in the genetic testing and diagnostics sector, focusing on the early detection of diseases in oncology and women's health. Despite facing competition, Natera aims to provide innovative healthcare solutions. Recently, the company has been under scrutiny by Halper Sadeh LLC for potential breaches of fiduciary duties by its officers and directors, which could lead to significant corporate actions.On October 27, 2025, an analyst from BNP Paribas set a price target ...